openPR Logo
Press release

Herpes Zoster (Shingles) Market Research Report Forecast to 2015- 2023

01-17-2017 09:39 PM CET | Health & Medicine

Press release from: Transparency Market Research - Pharmaceutical

Herpes Zoster (Shingles) Market Research Report Forecast

Transparency Market Research presents this most up-to-date research on "Herpes Zoster (Shingles) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 – 2024"

Herpes Zoster also known as zoster or shingles is a painful contagious viral disease which is characterized by blisters in limited area and painful skin rashes. These blisters full of liquid and pus appear on either side of the body or face, left or right in a single stripe. This disease is caused by varicella zoster virus which develops short lived or acute illness named as chickenpox that is usually seen in young adults and children. Patients who never got chickenpox cannot get shingles. The onset of the infection caused by this virus is also seen years after the episode of chicken pox has been resolved as at that time varicella virus is not eliminated completely from the body. Though shingles can develop at any age, people who had chickenpox before the age of 1 and people who are above the age of 60 are more likely to develop this condition. Senior citizens (aged 60 and above). People whose immune system is weakened by medications or disease are also likely to develop this condition. Diagnosis usually depends on the signs and synonyms of the person. After the resolution of chicken pox herpes virus remains in latent phase in nerve cell bodies or in non-neuronal satellite cells of the cranial nerve, autonomic ganglia or dorsal root. However, after decades the virus is again activated due to weakening of immune system that might occur owing to fever, aging or stress. The virus may spread from one nerve ganglia to another of an affected skin area. Headache, fever, nausea and malaise are the earlier symptoms of herpes zoster which may also result in incorrect diagnosis. However, these symptoms may be followed by itching, burning pain, oversensitivity or numbness. Over this area rash or band strip is developed which turns into blisters few days later. This blister is filled with fluid that usually takes 2 weeks to 4 weeks to recover.

View Full Report at : http://www.transparencymarketresearch.com/herpes-zoster-market.html

Furthermore, for the prevention of viral infection vaccines are prescribed to prevent an individual from developing severe shingles complications or symptoms. Zostavax is a live vaccine that is marketed for VZV. These vaccines are recommended by the Advisory Committee on Immunization Practices (ACIP), U.S. to reduce the risk of shingles and its associated pain in people aged over 60 years. In England annual incidence of shingles for those aged 70 years to 79 years is anticipated to be around 800 to 900 cases per 100,000 people.

Geographically, North America is the leading geography followed by the European market. Market growth of these regions is accounted due to presence of large base of population suffering from shingles. Asia-Pacific and Rest of the world region in the future are expected to emerge as fastest growing economies in this market.

Highlights of the report:

A complete backdrop analysis, which includes an assessment of the parent market

Important changes in market dynamics

Market segmentation up to the second or third level

Historical, current, and projected size of the market from the standpoint of both value and volume

Reporting and evaluation of recent industry developments

Market shares and strategies of key players

Emerging niche segments and regional markets

An objective assessment of the trajectory of the market

Recommendations to companies for strengthening their foothold in the market

Download Sample Copy of Report at :

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14999

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact

Mr.Sudip S

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Herpes Zoster (Shingles) Market Research Report Forecast to 2015- 2023 here

News-ID: 415197 • Views:

More Releases from Transparency Market Research - Pharmaceutical

Neurovascular Devices Market Business Opportunities and Growth Challenges Report
Neurovascular Devices Market Business Opportunities and Growth Challenges Report
Global Neurovascular Devices Market: Overview The global population is aging rapidly. According to WHO, the chances of health risks are greater in geriatric people than the young generation. Old age is considered to be one of the biggest risk factors that are responsible for developing various diseases such as cardiovascular and neurological conditions. It is because of these factors, the global neurovascular devices market is experiencing robust growth in the
Pneumococcal Vaccines Market anticipated expand at a CAGR of 3.3% from 2018 to 2026
Pneumococcal Vaccines Market anticipated expand at a CAGR of 3.3% from 2018 to 2 …
Transparency Market Research (TMR) has published a new report titled, “Pneumococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global pneumococcal vaccines market was valued at US$ 7,247.6 Mn in 2017 and is anticipated expand at a CAGR of 3.3% from 2018 to 2026. Increase in patient pool, growth of the pharmaceutical industry, government initiatives to increase vaccination programs, rise
Swab and Viral Transport Medium Market projected to expand at a CAGR of ~3% from 2020 to 2030
Swab and Viral Transport Medium Market projected to expand at a CAGR of ~3% from …
Swab and Viral Transport Medium Market: Introduction Transparency Market Research has published a new report titled, ‘Global Swab and Viral Transport Medium Market ’. According to the report, the global swab and viral transport medium market was valued at US$ 0.9 Bn in 2019 and is projected to expand at a CAGR of ~3% from 2020 to 2030. Viral transport medium (VTM) enables safe transfer of viruses, chlamydia, and mycoplasma for
Radiofrequency Ablation Devices Market by Product, Geography and Forecast to 202 …
Transparency Market Research (TMR) has published a new report titled, 'Radiofrequency Ablation Devices for Pain Management Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027'. According to the report, the global radiofrequency ablation devices for pain management market was valued at US$ 543.0 Mn in 2018 and is projected to expand at a CAGR of above 11.0% from 2019 to 2027. Overview Radiofrequency ablation is a minimally invasive surgical

All 5 Releases


More Releases for Herpes

Global Herpes Labialis (Oral Herpes) Drugs Market Future Analysis Report 2018-20 …
This report studies the global market size of Herpes Labialis (Oral Herpes) Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Herpes Labialis (Oral Herpes) Drugs in these regions. This research report categorizes the global Herpes Labialis (Oral Herpes) Drugs market by players/brands, region, type and application. This report also studies the global market status, competition
Drugs for Herpes Labialis (Oral Herpes) Market: GSK, Novartis, Teva, Mylan
HTF MI recently broadcasted a new study in its database that highlights the in-depth market analysis with future prospects of Drugs for Herpes Labialis (Oral Herpes) market. The study covers significant data which makes the research document a handy resource for managers, industry executives and other key people get ready-to-access and self-analyzed study along with graphs and tables to help understand market trends, drivers and market challenges. Some of the
Global Herpes Labialis (Oral Herpes) Clinical Trials Assessment & Evaluation, H2 …
Market Research Hub (MRH) has include a fresh report to its database titled “Herpes Labialis (Oral Herpes) Global Clinical Trials Review, H2, 2017”, an overview of trial numbers along with the average enrollment in major countries conducted across the globe. Furthermore, the report also presents prominent drugs for in-progress trials based on the count of ongoing trails. Request Free Sample Report@ https://www.marketresearchhub.com/enquiry.php?type=S&repid=1350157 Oral herpes is a type of infection which occurs on
Worldwide Herpes Labialis (Oral Herpes) Drugs Information and Market Trend Resea …
Global Herpes Labialis (Oral Herpes) Drugs Market Research Report 2017"" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. Description- In this report, the global Herpes Labialis (Oral Herpes) Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented
Global Drugs For Herpes Labialis (Oral Herpes) Market 2017 - Teva, Mylan, Cadila …
Apex Market Reports, recently published a detailed market research study focused on the "Drugs For Herpes Labialis (Oral Herpes) Market" across the global, regional and country level. The report provides 360° analysis of "Drugs For Herpes Labialis (Oral Herpes) Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Drugs For
Drugs for Herpes Labialis (Oral Herpes) Market 2017- Teva, Apotex, Cadila, Mylan …
Apex Research, recently published a detailed market research study focused on the "Drugs for Herpes Labialis (Oral Herpes) Market" across the global, regional and country level. The report provides 360° analysis of "Drugs for Herpes Labialis (Oral Herpes) Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Drugs for Herpes Labialis (Oral